BB BIOTECH AG

Q4 2023 13F Notice

Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen
Holdings as of
31 Dec 2023
Filing time
14 Feb 2024, 12:17:56 UTC
Form type
13F-NT
Description
No holdings are reported in this report, and all US holdings are reported by other reporting manager(s). Top holdings included .
Previous filing
Q1 2019 - 13 May 2019
SEC
View on sec.gov

BB BIOTECH AG didn't report any stock holdings as of Q4 2023.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Martin Gubler / Ivo Betschart SIGNING AUTHORITY Kuesnacht, Switzerland 12 Feb 2024

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $5,276,933,294 Zurich 028-17462